<DOC>
	<DOCNO>NCT02102932</DOCNO>
	<brief_summary>The aim trial ass relative bioavailability fix dose combination tablet Empagliflozin metformin compare administration single tablet ( Empagliflozin metformin ) Chinese subject . The availability fix dose combination tablet expect significantly enhance patient 's compliance antidiabetic treatment , particular concern frequent polypharmacy diabetic patient .</brief_summary>
	<brief_title>Bioavailability Empagliflozin/Metformin Fixed Dose Combinations ( FDCs ) Healthy Chinese Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject Exclusion criterion : Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>